Lincoln National Corp’s Quest Diagnostics DGX Stock Holding History

Lincoln National Corp’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,796	Closed	-$239K	–	270
2024 Q1	$239K	Buy	1,796 +74	+4%	+$9.6K	﹤0.01%	1062
2023 Q4	$237K	Buy	1,722 +65	+4%	+$8.54K	﹤0.01%	972
2023 Q3	$202K	Buy	+1,657	New	+$221K	﹤0.01%	968
2022 Q1	–	Sell	-1,399	Closed	-$242K	–	921
2021 Q4	$242K	Buy	1,399 +2	+0.1%	+$304	﹤0.01%	774
2021 Q3	$203K	Buy	+1,397	New	+$204K	﹤0.01%	817
2021 Q2	–	Sell	-2,159	Closed	-$277K	–	860
2021 Q1	$277K	Buy	2,159 +63	+3%	+$7.76K	0.01%	644
2020 Q4	$250K	Buy	2,096 +72	+4%	+$8.78K	0.01%	633
2020 Q3	$231K	Buy	2,024 +9	+0.4%	+$1.06K	0.01%	582
2020 Q2	$230K	Buy	+2,015	New	+$214K	0.01%	565

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lincoln National Corp's DGX Position: Q2 2024 in Review

Lincoln National Corp sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 1,796 shares — an estimated $239K sold.

Lincoln National Corp first reported a position in DGX in Q2 2020 and held it in 9 quarters. The position peaked at $277K in Q1 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

Lincoln National Corp reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
Lincoln National Corp sold 1,796 Quest Diagnostics shares in Q2 2024, an estimated $239K.
Lincoln National Corp first reported a position in Quest Diagnostics in Q2 2020 and held it in 9 quarters.
Lincoln National Corp's Quest Diagnostics position peaked at $277K in Q1 2021.
837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.